跳至主要内容
临床试验/JPRN-UMIN000007763
JPRN-UMIN000007763招募中未知

The comparison of the curative effect on benign prostatic hyperplasia between tamsulosin and naftopidil - The comparison between tamsulosin and naftopidil

Tokyo Medical University0 个研究点目标入组 60 人开始时间: 2012年4月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Male

入选标准

  • 未提供

排除标准

  • Active prostate cancer or history The present illness which affect urinary condision The history of the treatment with alfa 1 blocker and/or anticholinergic drug within 4 weeks The history of the treatment with 5 alfa reductase inhibitor on benign prostatic hyperplasia The history of the surgical treatment which affect urinary condition The contraindication of alfa 1 blocker The case which the chief urologist desides not adequate for the examination

研究者

相似试验